CLINICAL EVALUATION OF PRAZOSIN AS SOLE AGENT FOR TREATMENT OF HYPERTENSION - DOUBLE-BLIND CROSSOVER STUDY WITH METHYLDOPA

被引：0
|
作者：
BLOOM, DS
ROSENDORFF, C
KRAMER, R
机构：
[1] UNIV WITWATERSRAND, MED SCH, DEPT PHYSIOL, HOSPITAL ST, JOHANNESBURG, SOUTH AFRICA
[2] UNIV WITWATERSRAND, MED SCH, DEPT MED, JOHANNESBURG, SOUTH AFRICA
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1975年 / 18卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：144 / 150
页数：7
相关论文
共 50 条
  • [1] PRAZOSIN - NEW HYPERTENSIVE AGENT - DOUBLE-BLIND CROSSOVER STUDY IN TREATMENT OF HYPERTENSION
    SCHIRGER, A
    SHEPS, SG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (10): : 989 - 991
  • [2] PRAZOSIN IN HYPERTENSION - DOUBLE-BLIND EVALUATION WITH METHYLDOPA AND PLACEBO
    MROCZEK, WJ
    FOTIU, S
    DAVIDOV, ME
    FINNERTY, FA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1974, 16 (08): : 769 - 777
  • [3] PRAZOSIN TREATMENT OF RAYNAUDS-PHENOMENON - A DOUBLE-BLIND SINGLE CROSSOVER STUDY
    RUSSELL, IJ
    LESSARD, JA
    JOURNAL OF RHEUMATOLOGY, 1985, 12 (01) : 94 - 98
  • [4] DOUBLE BLIND CROSS-OVER STUDY COMPARING PRAZOSIN AND METHYLDOPA IN TREATMENT OF MILD HYPERTENSION
    VERHIEST, W
    CROONENBERGHS, J
    DEVOS, P
    FAGARD, R
    AMERY, A
    ACTA CARDIOLOGICA, 1974, 29 (03) : 217 - 233
  • [5] COMPARISON OF PRAZOSIN AND METHYLDOPA IN ESSENTIAL-HYPERTENSION - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PARALLEL TRIAL
    WHELTON, PK
    RUSSELL, RP
    SOVASCHULZ, K
    WYNDHAM, R
    WALKER, WG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1979, 1 (06) : S28 - S37
  • [6] LABETALOL COMPARED WITH PROPRANOLOL IN THE TREATMENT OF HYPERTENSION - DOUBLE-BLIND CROSSOVER STUDY
    LEHTONEN, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1979, 25 (03): : 378 - 383
  • [7] METHYLDOPA AND METHOSERPIDINE IN HYPERTENSION - A DOUBLE-BLIND TRIAL
    FORRESTE.TM
    SHIRRIFF.GG
    LANCET, 1967, 1 (7482): : 141 - +
  • [8] CLINICAL PHARMACOLOGIC EVALUATION OF ANTIATHEROSCLEROTIC AGENT, PYRIDINOLCARBAMATE . A DOUBLE-BLIND CROSSOVER TRIAL IN TREATMENT OF ATHEROSCLEROSIS OBLITERANS
    SHIMAMOTO, T
    ATSUMI, T
    YAMASHITA, S
    MOTOMIYA, T
    ISOKANE, N
    ISHIOKA, T
    SAKUMA, A
    AMERICAN HEART JOURNAL, 1970, 79 (01) : 5 - +
  • [9] A DOUBLE-BLIND COMPARATIVE-STUDY OF DOXAZOSIN AND PRAZOSIN IN THE TREATMENT OF ESSENTIAL-HYPERTENSION
    FUKIYAMA, K
    OMAE, T
    IIMURA, O
    YOSHINAGA, K
    YAGI, S
    INAGAKI, Y
    ISHII, M
    KANEKO, Y
    YAMADA, K
    IJICHI, H
    TAKEDA, T
    KURAMOCHI, M
    KOKUBU, T
    EBIHARA, A
    NAKASHIMA, M
    AMERICAN HEART JOURNAL, 1991, 121 (01) : 317 - 322
  • [10] DOSE-TITRATED, DOUBLE-BLIND, CROSSOVER COMPARISON OF A SELECTIVE BETA-BLOCKER AND METHYLDOPA IN TREATMENT OF HYPERTENSION
    ROUTLEDGE, PA
    ZRINZO, LV
    RAO, JG
    WALDEN, RJ
    DAVIES, DM
    RAWLINS, MD
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (03) : 159 - 162
12345